603520.SS

Zhejiang Starry Pharmaceutical Co.,Ltd. [603520.SS] Stock Forecast

Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000

603520.SS Stock Summary

Top 10 Correlated ETFs

603520.SS

Top 10 Correlated Stocks

603520.SS

In the News

603520.SS Financial details

Company Rating
-
Market Cap
4.17B
Income
-61.76M
Revenue
2.39B
Book val./share
-
Cash/share
-
Dividend
0.2
Dividend %
1.53%
Employees
1.84K
Optionable
No
Shortable
Yes
Earnings
19 Apr 2024
P/E
-69.42
Forward P/E
-
PEG
5.81
P/S
1.88
P/B
2.44
P/C
-
P/FCF
-16.15
Quick Ratio
0.45
Current Ratio
0.82
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
-0.19
EPS next Y
-
EPS next Q
-
EPS this Y
-122.11%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
NAN%
Revenue last 5Y
19.07%
Revenue Q/Q
5.61%
EPS Q/Q
-84.29%
-
-
-
-
SMA20
-5.17%
SMA50
-4.07%
SMA100
-21.35%
Inst Own
-
Inst Trans
-
ROA
-1%
ROE
-4%
ROC
-0.02%
Gross Margin
23%
Oper. Margin
-2%
Profit Margin
-3%
Payout
-280%
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
7.86-18.78
52W High
-53.22%
52W Low
+20.29%
RSI
52.73
Rel Volume
1.94
Avg Volume
7.51M
Volume
14.53M
Perf Week
1.81%
Perf Month
-1.52%
Perf Quarter
-3.22%
Perf Half Y
-10.81%
-
-
-
-
Beta
0.491
-
-
Volatility
0.12%, 0.28%
Prev Close
3.69%
Price
8.42
Change
4.34%

603520.SS Financial Performance

603520.SS Dividend History

603520.SS Frequently Asked Questions

What is Zhejiang Starry Pharmaceutical Co.,Ltd. stock symbol ?

Zhejiang Starry Pharmaceutical Co.,Ltd. is a CN stock and trading under the symbol 603520.SS

What is Zhejiang Starry Pharmaceutical Co.,Ltd. stock quote today ?

Zhejiang Starry Pharmaceutical Co.,Ltd. stock price is $8.42 today.

Is Zhejiang Starry Pharmaceutical Co.,Ltd. stock public?

Yes, Zhejiang Starry Pharmaceutical Co.,Ltd. is a publicly traded company.

Something similar

Top by Market Cap
AVGO
APC.DE
FB2A.DE
EMBASSY.NS
NVD.DE
Top Correlated ETFs
KBWP
KIE
IAK
HDLB
HDV
Top Correlated Stocks
600867.SS
002275.SZ
002399.SZ
600196.SS
600997.SS
Similar Market Cap
T6A.DE
FRO
0JXQ.L
1310.HK
4261.SR

Company Profile

Healthcare Drug Manufacturers - Specialty & Generic
  • Volume Average 7.51M
  • Market Capitalization 4.17B
  • Employee 1.84K
  • CEO Mr. Weiyi Shen
  • Headquarters Xianju,CN
  • IPO Date 2016-03-09
  • Website https://www.starrypharm.com

Zhejiang Starry Pharmaceutical Co.,Ltd. engages in the research and development, production, and sale of X-CT non-ionic contrast agents and fluoroquinolones drugs and intermediates in China and internationally. Its contrast agent products include iohexol, iohexol hydrolysate, iohexol iodide, ioversol, iopamidol, iomeprol, iopromide, cybeclamine, iodixanol, gadopentetic acid dimeglumine, and glutamate; and fluoroquinolones products comprise levofloxacin, levofloxacin hydrochloride, levoflurane, levofluorocarboxylic acid, pazufloxacin, and pazufloxacin mesylate. The company was founded in 1997 and is based in Xianju, China.